Publicité
Publicité

MYNZ

MYNZ logo

Mainz Biomed N.V. Ordinary Shares

1.18
USD
Sponsorisé
0.00
+0.43%
09 janv., 15:58 UTC -5
Fermé
exchange

Après-marché

1.17

-0.01
-1.27%

MYNZ Rapports sur les bénéfices

Ratio de surprise positive

MYNZ a dépassé 2 des 4 dernières estimations.

50%

Prochain rapport

Date du prochain rapport
30 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.04
Variation implicite de Q2 25 (Revenue/ EPS)
--
/
--
Variation implicite de Q4 24 (Revenue/ EPS)
--
/
--

Mainz Biomed N.V. Ordinary Shares earnings per share and revenue

On 26 sept. 2025, MYNZ reported earnings of -- USD per share (EPS) for Q2 25, -- the estimate of -2.44 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analystes forecast an EPS of -2.04 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q2 2025, Mainz Biomed N.V. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 30 mars 2026.
Based on 3 analystes, Mainz Biomed N.V. Ordinary Shares is expected to report EPS of -$2.04 and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité